Get started
Author

Tomoyuki Suehiro

Expression of interleukin-11 (IL-11) and IL-11 receptor alpha in human gastric carcinoma and IL-11 upregulates the invasive activity of human gastric carcinoma cells.
2007 · Toshiyuki Nakayama, Ayumi Yoshizaki, et al. · PubMed · 91
Serum exosomal microRNA‑122 and microRNA‑21 as predictive biomarkers in transarterial chemoembolization‑treated hepatocellular carcinoma patients
2018 · Tomoyuki Suehiro, Hisamitsu Miyaaki, et al. · Oncology Letters · 66
PDF
Enhanced Hepatic Nrf2 Activation After Ursodeoxycholic Acid Treatment in Patients with Primary Biliary Cirrhosis
2010 · Kazuhito Kawata, Yoshimasa Kobayashi, et al. · Antioxidants and Redox Signaling · 58
Serum kynurenine levels are a novel biomarker to predict the prognosis of patients with hepatocellular carcinoma
2020 · Shigemune Bekki, Satoru Hashimoto, et al. · PLoS ONE · 25
PDF
iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study
2024 · Masashi Hirooka, Sadanobu Ogawa, et al. · Journal of Gastroenterology · 17
PDF
A genome-wide association study identified PTPN2 as a population-specific susceptibility gene locus for primary biliary cholangitis
2024 · Yuki Hitomi, Kazuko Ueno, et al. · Hepatology · 14
Diagnostic performance of shear wave measurement in the detection of hepatic fibrosis: A multicenter prospective study
2024 · Takashi Kumada, Hidenori Toyoda, et al. · Hepatology Research · 6
PDF
Ketone bodies as a predictor of prognosis of hepatocellular carcinoma after transcatheter arterial chemoembolization
2018 · Ryu Sasaki, Naota Taura, et al. · Nutrition · 6
PDF
Expression of interleukin-11 (IL-11) and IL-11 receptor α in human gastric carcinoma and IL-11 upregulates the invasive activity of human gastric carcinoma cells
2007 · Toshiyuki Nakayama, Ayumi Yoshizaki, et al. · International Journal of Oncology · 5
PDF
Zinc supplementation with polaprezinc was associated with improvements in albumin, prothrombin time activity, and hemoglobin in chronic liver disease
2023 · Seigo Abiru, Yuki Kugiyama, et al. · Journal of Clinical Biochemistry and Nutrition · 4
PDF
Lactitol may improve the prognosis of hepatocellular carcinoma through the proliferation of Megasphaera as well as Bifidobacterium
2025 · Seigo Abiru, Yuki Kugiyama, et al. · Frontiers in Medicine · 2
PDF
Hemorrhagic radiation gastritis successfully treated with repeated intra-arterial steroid infusions
2010 · Kazuhito Kawata, Yoshimasa Kobayashi, et al. · Clinical Journal of Gastroenterology · 2
A case of hepatocellular carcinoma with bile duct invasion treated successfully by expandable metallic stents and transcatheter arterial chemoembolization (TACE)
2009 · Takeshi Chida, Fujito Kageyama, et al. · Kanzo · 2
PDF
Changes in serum myostatin levels among patients with type C liver cirrhosis treated with direct‐acting antivirals
2025 · Tomoyuki Suehiro, Hideko Kozuru, et al. · Hepatology Research · 1
PDF
On‐Treatment Reassessment of Type IV Collagen 7S and M2BPGi‐Qt Improves Long‐Term Hepatocellular Carcinoma Risk Stratification in Chronic Hepatitis B
2026 · Kazumi Yamasaki, Hideko Kozuru, et al. · Hepatology Research
PDF
WED-638 Combined use of aMAP risk score and M2BPGi for stratifying hepatocellular carcinoma risk after SVR following direct-acting antiviral therapy
2026 · Tomoyuki Suehiro, Tomohito Kojima, et al. · Journal of Hepatology
WED-618 Evaluation of clinical performance and utility of the combined HCV antigen-antibody assay (HCV Duo)
2026 · Kazumi Yamasaki, Tatsuya Fujino, et al. · Journal of Hepatology
SAT-522 Diagnostic performance of the ELF score for liver fibrosis staging in chronic liver disease: a comparative study with FibroScan, serum markers, and liver biopsy
2026 · Tatsuya Fujino, Shingo Namino, et al. · Journal of Hepatology
Serum soluble PD-L1 predicts hepatocellular carcinoma development across distinct virological cohorts of chronic hepatitis C
2026 · Kazumi Yamasaki, Masashi Mizokami, et al. · Hepatology International
FRI-304 Bioinformatic analysis of the spatial transcriptomes of inflamed portal tracts in human primary biliary cholangitis
2025 · Atsumasa Komori, Yuki Kugiyama, et al. · Journal of Hepatology
WED-203 Evaluation of iATT liver fat quantification for steatosis grading with reference to magnetic resonance imaging-based proton density fat fraction: a multicenter study
2024 · Masashi Hirooka, Sadanobu Ogawa, et al. · Journal of Hepatology
WED-286 Identification of serum metabolome signatures associated with hepatocellular carcinoma in metabolic dysfunction-associated steatohepatitis
2024 · Atsumasa Komori, Kosuke Matsumoto, et al. · Journal of Hepatology
Serum myostatin decreased after direct acting antivirals for cirrhotic patients
2023 · Tomoyuki Suehiro, Kosuke Matsumoto, et al. · Journal of Hepatology
Usefulness of serum CCL20 as a post sustained viral response biomarker for HCV-associated liver fibrosis
2023 · Atsumasa Komori, Kosuke Matsumoto, et al. · Journal of Hepatology
A Novel Algorithm for the Personalized Assessment of 5-Year Risk of Hepatocellular Carcinoma after Eradication of Hepatitis C Virus Infection
2023 · Kazumi Yamasaki, Jun Ohashi, et al. · SSRN Electronic Journal
Works count: 34
Citation count: 299
H-index: 6
I10-index: 6
Year
Topic
Type